Background Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) causes
progressive or relapsing weakness and numbness of the limbs, which lasts for at least two …

Background Chronic inflammatory demyelinating polyneuropathy (CIDP) is a rare
neurological disorder characterised by muscle weakness and impaired sensory function …

Guillain Barré syndrome (GBS) and its variants, and chronic inflammatory demyelinating
polyradiculoneuropathy (CIDP and its variants, are regarded as immune mediated …

Introduction Chronic inflammatory demyelinating polyneuropathy (CIDP) is a disorder in
which early effective treatment is important to minimize disability from axonal degeneration …

Chronic inflammatory demyelinating polyneuropathy (CIDP) is an immune-mediated
demyelinating disease of the peripheral nervous system (PNS). A small number of CIDP …

Experimental autoimmune neuritis is a common animal model for acute human immune–
mediated polyneuropathies. Although already established in 1955, a number of …

Objective Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is an immune‐
mediated disease that targets the myelin sheaths of the peripheral nerves. Fingolimod is a …

Nowadays intravenous immunoglobulin (IVIg) treatment is considered to play a promising
role in the autoimmune disease therapy. Despite its significant beneficial effects, the precise …

This prospective, multicenter, single‐arm, open‐label phase 3 study aimed to evaluate the
efficacy and safety of IqYmune in patients with chronic inflammatory demyelinating …

Abstract Background and Aims The ProCID study evaluated the efficacy and safety of three
doses of a 10% liquid intravenous immunoglobulin (IVIg) preparation (panzyga®) in patients …